Higher stem cell dose infusion after intensive chemotherapy does not improve symptom burden in older patients with multiple myeloma and amyloidosis

Autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma (MM) is associated with high symptom burden, particularly for older patients and those with amyloid light-chain (AL) amyloidosis. Symptom burden peaks during leukopenia. We hypothesized that higher doses of CD34(+) stem c...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Biol Blood Marrow Transplant
मुख्य लेखकों: Shah, Nina, Shi, Qiuling, Williams, Loretta A., Mendoza, Tito R., Wang, Xin Shelley, Reuben, James M., Dougherty, Patrick M., Bashir, Qaiser, Qazilbash, Muzaffar H., Champlin, Richard E., Cleeland, Charles S., Giralt, Sergio A.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2015
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4716870/
https://ncbi.nlm.nih.gov/pubmed/26253006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.07.036
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन